PPAR-alpha and PPAR-beta expression changes in the hippocampus of rats undergoing global cerebral ischemia/reperfusion due to PPAR-gamma status

Table 1 Effects of rosiglitozane on IL-1b,IL-6,IL-10 and TNF-a content (n = 5)

Group	IL-1β	IL-6	IL-10	TNF-α
	(mg/ml)	(ng/ml)	(ng/ml)	(ng/ml)
sham control	218.35 ± 42.2	6.37 ± 0.43	3.01 ± 0.25	2.19 ± 0.35
IR	561.31 ± 49.98**	15.83 ± 1.37*	1.86 ± 0.15**	6.36 ± 1.11**
0.8 mg/kg Ros	505.11 ± 39.28**	13.27 ± 0.89**	2.81 ± 0.37**	5.57 ± 0.43**
2.4 mg/kg Ros	437.71 ± 51.74^**##	10.27 ± 0.516^**##	2.37 ± 0.25^**##	4.23 ± 0.61^**##
7.2 mg/kg Ros	390.22 ± 42.08^##	8.05 ± 0.95^##	2.01 ± 0.31^##	3.39 ± 0.37^##
7.2 mg/kg Ros plus GW9662	572.40 ± 33.27**	16.17 ± 1.12**	1.95 ± 0.17**	6.19 ± 1.01**
GW9662 in sham control	233.57 ± 28.33	6.07 ± 0.33	3.21 ± 0.35	2.45 ± 0.22

Datas are expressed as mean ± SD (n = 5). * and **:P < 0.05 and 0.01, vs. sham control; ^# and ^##:P < 0.05 and 0.01 vs. IR.